605 related articles for article (PubMed ID: 34581622)
21. Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus.
Gribaudo G; Lembo D; Cavallo G; Landolfo S; Lengyel P
J Virol; 1991 Apr; 65(4):1748-57. PubMed ID: 1705989
[TBL] [Abstract][Full Text] [Related]
22. The Activation Mechanism of 2'-5'-Oligoadenylate Synthetase Gives New Insights Into OAS/cGAS Triggers of Innate Immunity.
Lohöfener J; Steinke N; Kay-Fedorov P; Baruch P; Nikulin A; Tishchenko S; Manstein DJ; Fedorov R
Structure; 2015 May; 23(5):851-862. PubMed ID: 25892109
[TBL] [Abstract][Full Text] [Related]
23. Role of helical structure and dynamics in oligoadenylate synthetase 1 (OAS1) mismatch tolerance and activation by short dsRNAs.
Schwartz SL; Dey D; Tanquary J; Bair CR; Lowen AC; Conn GL
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017296
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of a common splice site polymorphism on the generation of OAS1 variants in human bronchial epithelial cells.
Noguchi S; Hamano E; Matsushita I; Hijikata M; Ito H; Nagase T; Keicho N
Hum Immunol; 2013 Mar; 74(3):395-401. PubMed ID: 23220500
[TBL] [Abstract][Full Text] [Related]
25. The ribonuclease L-dependent antiviral roles of human 2',5'-oligoadenylate synthetase family members against hepatitis C virus.
Kwon YC; Kang JI; Hwang SB; Ahn BY
FEBS Lett; 2013 Jan; 587(2):156-64. PubMed ID: 23196181
[TBL] [Abstract][Full Text] [Related]
26. Quelling an innate response to dsRNA.
Ogden KM; Prasad BV
Oncotarget; 2015 Oct; 6(30):28535-6. PubMed ID: 26356565
[No Abstract] [Full Text] [Related]
27. Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling.
Li Y; Dong B; Wei Z; Silverman RH; Weiss SR
mBio; 2019 Nov; 10(6):. PubMed ID: 31719180
[TBL] [Abstract][Full Text] [Related]
28. Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort.
Skerenova M; Cibulka M; Dankova Z; Holubekova V; Kolkova Z; Lucansky V; Dvorska D; Kapinova A; Krivosova M; Petras M; Baranovicova E; Baranova I; Novakova E; Liptak P; Banovcin P; Bobcakova A; Rosolanka R; Janickova M; Stanclova A; Gaspar L; Caprnda M; Prosecky R; Labudova M; Gabbasov Z; Rodrigo L; Kruzliak P; Lasabova Z; Matakova T; Halasova E
Adv Med Sci; 2024 Mar; 69(1):198-207. PubMed ID: 38555007
[TBL] [Abstract][Full Text] [Related]
29. OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug.
Banerjee S; Gusho E; Gaughan C; Dong B; Gu X; Holvey-Bates E; Talukdar M; Li Y; Weiss SR; Sicheri F; Saunthararajah Y; Stark GR; Silverman RH
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5071-5076. PubMed ID: 30814222
[TBL] [Abstract][Full Text] [Related]
30. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19.
Huffman JE; Butler-Laporte G; Khan A; Pairo-Castineira E; Drivas TG; Peloso GM; Nakanishi T; ; Ganna A; Verma A; Baillie JK; Kiryluk K; Richards JB; Zeberg H
Nat Genet; 2022 Feb; 54(2):125-127. PubMed ID: 35027740
[TBL] [Abstract][Full Text] [Related]
31. Condensation of RNase L promotes its rapid activation in response to viral infection in mammalian cells.
Cusic R; Burke JM
Sci Signal; 2024 May; 17(837):eadi9844. PubMed ID: 38771918
[TBL] [Abstract][Full Text] [Related]
32. Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A.
Silverman RH; Weiss SR
J Interferon Cytokine Res; 2014 Jun; 34(6):455-63. PubMed ID: 24905202
[TBL] [Abstract][Full Text] [Related]
33. [OAS genes and susceptibility to West Nile virus].
Guénet JL; Després P
Med Sci (Paris); 2003 Jan; 19(1):9-12. PubMed ID: 12836183
[No Abstract] [Full Text] [Related]
34. Heterozygous
Magg T; Okano T; Koenig LM; Boehmer DFR; Schwartz SL; Inoue K; Heimall J; Licciardi F; Ley-Zaporozhan J; Ferdman RM; Caballero-Oteyza A; Park EN; Calderon BM; Dey D; Kanegane H; Cho K; Montin D; Reiter K; Griese M; Albert MH; Rohlfs M; Gray P; Walz C; Conn GL; Sullivan KE; Klein C; Morio T; Hauck F
Sci Immunol; 2021 Jun; 6(60):. PubMed ID: 34145065
[TBL] [Abstract][Full Text] [Related]
35. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.
Lim JK; Lisco A; McDermott DH; Huynh L; Ward JM; Johnson B; Johnson H; Pape J; Foster GA; Krysztof D; Follmann D; Stramer SL; Margolis LB; Murphy PM
PLoS Pathog; 2009 Feb; 5(2):e1000321. PubMed ID: 19247438
[TBL] [Abstract][Full Text] [Related]
36. New insights into the role of RNase L in innate immunity.
Chakrabarti A; Jha BK; Silverman RH
J Interferon Cytokine Res; 2011 Jan; 31(1):49-57. PubMed ID: 21190483
[TBL] [Abstract][Full Text] [Related]
37. Bat Mx1 and Oas1, but not Pkr are highly induced by bat interferon and viral infection.
Zhou P; Cowled C; Wang LF; Baker ML
Dev Comp Immunol; 2013; 40(3-4):240-7. PubMed ID: 23541614
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection.
Yousfi FZE; Haroun AE; Nebhani C; Belayachi J; Askander O; Fahime EE; Fares H; Ennibi K; Abouqal R; Razine R; Bouhouche A
Arch Virol; 2024 Apr; 169(5):109. PubMed ID: 38658463
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2-Encoded MiRNAs Inhibit Host Type I Interferon Pathway and Mediate Allelic Differential Expression of Susceptible Gene.
Zhu Y; Zhang Z; Song J; Qian W; Gu X; Yang C; Shen N; Xue F; Tang Y
Front Immunol; 2021; 12():767726. PubMed ID: 35003084
[TBL] [Abstract][Full Text] [Related]
40. The Many Faces of Oligoadenylate Synthetases.
Sarkar SN; Harioudh MK; Shao L; Perez J; Ghosh A
J Interferon Cytokine Res; 2023 Nov; 43(11):487-494. PubMed ID: 37751211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
